Nathalie de Castro

InstitutionSaint-Louis Hospital
AddressFrance
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 2 publications in July 2021
    All Publications
    Bar chart showing 56 publications over 18 distinct years, with a maximum of 6 publications in 2007 and 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gudiol C, Durà-Miralles X, Aguilar-Company J, Hernández-Jiménez P, Martínez-Cutillas M, Fernandez-Avilés F, Machado M, Vázquez L, Martín-Dávila P, de Castro N, Abdala E, Sorli L, Andermann TM, Márquez-Gómez I, Morales H, Gabilán F, Ayaz CM, Kayaaslan B, Aguilar-Guisado M, Herrera F, Royo-Cebrecos C, Peghin M, González-Rico C, Goikoetxea J, Salgueira C, Silva-Pinto A, Gutiérrez-Gutiérrez B, Cuellar S, Haidar G, Maluquer C, Marin M, Pallarès N, Carratalà J. Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study. J Infect. 2021 09; 83(3):306-313. PMID: 34302864.
      Citations: 3     Fields:    Translation:Humans
    2. Vallet N, Chevret S, Feghoul L, Aguinaga L, Bondeelle L, Kaphan E, Bertinchamp R, Soret J, Villesuzanne C, De Castro N, Sebert M, Boutboul D, Lengline E, Tudesq JJ, Rabian F, Adès L, Xhaard A, Di Blasi R, Raffoux E, Galicier L, Le Goff J, Delaugerre C, Bergeron A, Harel S. Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospital. Blood Cancer J. 2021 07 14; 11(7):129. PMID: 34262018.
      Citations:    Fields:    Translation:Humans
    3. Bondeelle L, Chevret S, Cassonnet S, Harel S, Denis B, de Castro N, Bergeron A. Profiles and outcomes in patients with COVID-19 admitted to wards of a French oncohematological hospital: A clustering approach. PLoS One. 2021; 16(5):e0250569. PMID: 34010331.
      Citations:    Fields:    Translation:Humans
    4. Peffault de Latour R, Bergeron A, Lengline E, Dupont T, Marchal A, Galicier L, de Castro N, Bondeelle L, Darmon M, Dupin C, Dumas G, Leguen P, Madelaine I, Chevret S, Molina JM, Azoulay E, Fremeaux-Bacchi V. Complement C5 inhibition in patients with COVID-19 - a promising target? Haematologica. 2020 12 01; 105(12):2847-2850. PMID: 33256385.
      Citations: 18     Fields:    Translation:Humans
    5. Molina JM, Molina JM, Delaugerre C, Le Goff J, Mela-Lima B, Ponscarme D, Goldwirt L, de Castro N. No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection. Med Mal Infect. 2020 06; 50(4):384. PMID: 32240719.
      Citations: 340     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials